ficusin has been researched along with Bone Loss, Osteoclastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gan, GX; Li, JP; Li, WJ; Li, YH; Shi, LY; Xie, BP; Zeng, Y; Zhang, WJ | 1 |
Chai, L; Fan, N; Fan, X; Hu, L; Li, J; Tan, X; Wang, S; Zhang, H; Zhou, K | 1 |
Han, W; Jia, Y; Lu, X; Qian, Y; Qin, A; Yang, W; Zhang, T; Zhao, K | 1 |
3 other study(ies) available for ficusin and Bone Loss, Osteoclastic
Article | Year |
---|---|
[Psoralen inhibits RAW264.7 differentiation into osteoclasts and bone resorption by regulating CD4+T cell differentiation].
Topics: Animals; Bone Resorption; CD4-Positive T-Lymphocytes; Cell Differentiation; Ficusin; Mice; Mice, Inbred BALB C; Osteoclasts; RANK Ligand; RAW 264.7 Cells | 2018 |
Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Cathepsin K; Cell Differentiation; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Ficusin; JNK Mitogen-Activated Protein Kinases; Macrophage Colony-Stimulating Factor; Matrix Metalloproteinases; Mice; Osteoclasts; Phenols; Proto-Oncogene Proteins c-akt; RANK Ligand; Signal Transduction; Tartrate-Resistant Acid Phosphatase; Transcription Factor AP-1; Transcription Factor RelA | 2018 |
Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.
Topics: Animals; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Core Binding Factor Alpha 1 Subunit; Female; Ficusin; Fracture Healing; Macrophages; NF-kappa B; NFATC Transcription Factors; Osteoblasts; Osteoclasts; Osteogenesis; p38 Mitogen-Activated Protein Kinases; RANK Ligand; Rats; Rats, Sprague-Dawley; Signal Transduction; Tartrate-Resistant Acid Phosphatase | 2019 |